Home/Enzyme by Design/Arnon Lavie, PhD

AL

Arnon Lavie, PhD

Co-founder, President, CEO, CSO, Director

Enzyme by Design

Therapeutic Areas

Oncology Hematological Malignancies

Enzyme by Design Pipeline

Drug	Indication	Phase
Engineered L-asparaginase	Acute Lymphoblastic Leukemia (ALL) / Hematological Malignancies	Pre-clinical

Leadership Team at Enzyme by Design

Amanda M. Schalk, PhD

Co-founder, COO, NIH Grants PI, Director

Gary Gordon, MD/PhD

Head of Clinical Development, Director

View full Enzyme by Design profile